Can nature’s own surfactants unlock the next generation of drug delivery?
In a new interview, ICE Pharma’s Chief Commercial Officer, Roger Viney, discusses how bile acids are transforming the way we tackle poor solubility and bioavailability—two of the biggest challenges in modern drug development.
By modulating permeability and adjusting the hydrophilic-lipophilic balance, bile acids enable drugs to cross biological barriers more effectively. Already used as excipients in oral and injectable formulations, their application is now expanding into transdermal and nasal delivery systems.
Watch the full interview to learn how ICE Pharma is driving innovation with bile acid-based excipients:
Learn more about ICE Pharma offering 👉 Products